This call for projects was initiated by Fund Sophia, which was created to support medical scientific research on neurodegenerative diseases and is managed by the King Baudouin Foundation in Brussels, Belgium. Priority will be given to research projects with focus… Continue Reading

Neurology is a rapidly developing field and many diseases have lost their poor or even fatal prognosis through scientific progress. Parkinson’s disease, multiple sclerosis, infections of the nervous system, epilepsies and many other diseases were barely untreatable only 50 years ago but can now be effectively treated and sometimes even cured. But all this progress needs to be brought to the patient. The providers who take care of this are the neurologists. Moreover, neurological disorders are among the most frequent diseases. This is increasingly recognised by the different European national health systems and luckily we have a constantly increasing number of neurologists in Europe. They are united in different national Societies and within the Academy at European level.

Top 10 Articles 2012 from keywords: Neurology, Neurological Sciences, Ageing and Dementia, Cerebroascular diseases/ Stroke, Clinical Neurophysiology, Cognitive neurology/neuropsychology, Critical care, Epilepsy, Headache and Pain, Infections & AIDS, Motorneurone diseases, Movement Disorders, Multiple sclerosis and Related Disorders, Muscle and neuromuscular… Continue Reading

As in the previous year, Neuropenews asked EAN committee members, panel chairs, speakers etc. which session one should not miss at the upcoming congress in Berlin, June 2015. Please find their answers below! Benedikt Schoser, speaker at Symposium 3 “Modern… Continue Reading

Gian Luigi Lenzi (GLL): As Treasurer of the EAN, can you illustrate the role you give to EAN within the community of European neurologists? Marianne de Visser (MdV): The Board is unanimous about the need to spend most of EAN’s income on educational activities. In the December issue of Neuropenews, President Deuschl expressed his concern about the increasing demand of neurologists and thus we need not only accommodate residents and young neurologists but also medical students should feel attracted to neurology.

Gian Luigi Lenzi (GLL): Ethical standards are an important aspect of H2020. How did the EC decide on these standards and who took part in their definition? Isidoros Karatzas (IK): The ethics standards are based on, for example, the principles of the European Charter of Fundamental Rights, the European Convention of Human rights (Article 19, Horizon 2020 regulation). Also on the relevant principles that flow from specific European and National legislation such as data protection and privacy, clinical trials etc. The Sector also follows and participates in the dialogue with the responsible Member States structures, such as the national Bioethics Committees, the network of Research Ethics Committees etc.

Like it or not, difficult decisions are part of neurological life, irrespective of your speciality interest, and all of us need to be prepared to support and help people who’s conditions we can’t cure. If you didn’t catch it live… Continue Reading

After the Second World War, the German education system was organised in a decentralised fashion in order to facilitate a pluralistic control of research and education. Therefore, educational and funding systems exist in parallel, on the level of the regional political structure (state) where a specific university is localised, and on the level of funding by the central government and its Federal Ministry of Education and Research (BMBF).

In the June issue of the European Journal of Neurology, members of the Subspecialty Scientific Panel Dementia and Cognitive Disorders panel of the European Academy of Neurology publish a Guideline on concomitant use of cholinesterase inhibitors (ChEI) and memantine in moderate to severe Alzheimer’s disease (AD).

For May 2015 we have selected: The CADISS trial investigators. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomized trial. Lancet Neurology 2015;14:361-367. The treatment of extracranial carotid and vertebral artery dissection is still empirical. There is not enough data currently supporting the efficacy of antiplatelet or anticoagulant treatment to prevent a secondary cerebral ischemic event, estimated around 15-20% in some observational studies.

by Delia Lenzi Usually when we ought to understand how things work, first we try to get to know the structure exactly. But in neurology and neuroscience we often face the problem of trying to understand the software without knowing… Continue Reading

Register until Wednesday, May 6th, 2015 and save up to € 35,00 on the registration fee! Find more information here!

The European Brain Council sends out a newsletter as well as an External Environmental Report that brings articles and projects of interest to the attention of its members. From these, the Neuropenews Editors identify those that are of interest for… Continue Reading

by Martin Rakusa Over 3000 neurologists, psychiatrists and neuroscientists have recently gathered together at the French Mediterranean coast. From 18th to 22nd of March, Nice hosted the 12th International Conference on Alzheimer’s and Parkinson’s Diseases and related Neurological Disorders (AD/PD… Continue Reading

... is online now! Click here to read.